Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2011, Vol. 16 ›› Issue (4): 435-438.

Previous Articles     Next Articles

Analysis of therapeutic effect of 80 cases patients with pelvic inflammation disease treated with Kangfu anti-inflammatory suppository combined with antibiotics

CHEN Lin-hai   

  1. Department of Gynaecology and Obstetrics of Yiwu Women and Children's Hospital, Yiwu 322000,Zhejiang,China
  • Received:2011-03-08 Revised:2011-03-14 Published:2011-06-22

Abstract: AIM: To evaluate the efficacy of treated pelvic inflammatory disease with Kangfu anti-inflammatory suppository and tinidazole. METHODS: 152 patients were diagnosed as pelvic inflammatory disease, who were divided into treated group(n=80)and control group(n=72). Treated group was treated with Kangfu anti-inflammatory suppository by rectal administration and oral tinidazole; Control group took tinidazole and amoxicillin orally or given an intravenous injection twice a day with ampicillin/sulbactam 3.0 g and metronidazole injection 100 mL. After three courses of treatment,the curative effect were compared between treated group and control group. RESULTS: The curative effect was good with Kangfu anti-inflammatory suppository combined with tinidazole treated pelvic inflammatory disease. The total effective rate were 97.5%,87.5%, respectively in treated group and control group.There was no statistical difference between the two groups. CONCLUSION: There is significant curative effect and less side effect on pelvic inflammatory disease treated with Kangfu anti-inflammatory suppository combined with tinidazole,which deserves the clinical expansion application.

Key words: Kangfu anti-inflammatory suppository, Pelvic inflammatory disease, Treatment, Efficacy

CLC Number: